8RBV

SARS-CoV-2 Spike-derived peptide S976-984 S982A mutant (VLNDILARL) presented by HLA-A*02:01

8RBV の概要

• エントリーDOI: 10.2210/pdb8rbv/pdb
• 分子名称: HLA class I antigen, Beta-2-microglobulin, SARS-CoV-2 Spike-derived peptide S976-984 S982A mutant, ... (8 entities in total)
• 機能のキーワード: human leukocyte antigen, major histocompatibility complex, hla-a2, hla-a*02:01, sars-cov-2, spike, immune system
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 54454.56

構造登録者

Ahn, Y.M.,Maddumage, J.C.,Szeto, C.,Gras, S. (登録日: 2023-12-05, 公開日: 2024-05-15, 最終更新日: 2024-05-22)

• 主引用文献: Ahn, Y.M.,Maddumage, J.C.,Grant, E.J.,Chatzileontiadou, D.S.M.,Perera, W.W.J.G.,Baker, B.M.,Szeto, C.,Gras, S.; The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific.; Curr Res Struct Biol, 7:100148-100148, 2024; PubMed: 38742159; DOI: 10.1016/j.crstbi.2024.100148

実験手法

X-RAY DIFFRACTION (1.8 Å)